Impact of a 24/7 Rapid Molecular Assay for Influenza Detection on the Prescription of Oseltamivir.
Hervé JacquierGauthier Péan de PonfillyAnthony ChauvinRishma AmarsyHana BenmansourDan-Thanh Hoang-NguyenEmmanuel LecorchéCéline MesnilFaiza MougariAnne-Lise MunierMaud SalmonaBéatrice BerçotJérôme Le GoffEmmanuelle CambauPublished in: Open forum infectious diseases (2020)
We assessed the impact of a rapid molecular assay for influenza detection whether outsourced or performed onsite 24/7 in a University Hospital in Paris, France. Shorter median time-to-results (16.8 vs 2.3 hours, P < .05) and an increased rate of adequate prescription of oseltamivir (76.6% vs 95.3%, P < .05) were observed.